ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2026

Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.

Luigi Spadafora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.